Bio-Rad Laboratories Inc (NYSE:BIO)
$ 330.53 2.17 (0.66%) Market Cap: 9.23 Bil Enterprise Value: 9.00 Bil PE Ratio: 0 PB Ratio: 1.24 GF Score: 78/100

Q4 2019 Bio Rad Laboratories Inc Earnings Call Transcript

Feb 13, 2020 / 10:00PM GMT
Release Date Price: $379.34 (+1.00%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Q4 and Full Year 2019 Bio-Rad Laboratories, Inc. Earnings Conference call. (Operator Instructions). Please be advised that today's conference may be recorded. (Operator Instructions). I would now like to hand the conference over to your speaker today, Mr. Ron Hutton. Thank you. Please go ahead, sir.

Ronald W. Hutton
Bio-Rad Laboratories, Inc. - VP & Treasurer

Thanks, Daniel. Good afternoon, and thank you all for joining us. Today, we will review the fourth quarter and full year financial results for 2019.

With me today are Norman Schwartz, our CEO; Ilan Daskal, Executive Vice President and Chief Financial Officer; Andy Last, Executive Vice President and Chief Operating Officer; Annette Tumolo, President of Life Science Group; and Dara Wright, President of the Clinical Diagnostics Group.

Before we begin our review, I would like to caution everyone that we will be making forward-looking statements about management's goals, plans and expectations, our future financial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot